117 related articles for article (PubMed ID: 7830233)
1. N-methyl-2-pyrrolidone as a cosolvent: relationship of cosolvent effect with solute polarity and the presence of proton-donating groups on model drug compounds.
Tarantino R; Bishop E; Chen FC; Iqbal K; Malick AW
J Pharm Sci; 1994 Sep; 83(9):1213-6. PubMed ID: 7830233
[TBL] [Abstract][Full Text] [Related]
2. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect.
Miyako Y; Khalef N; Matsuzaki K; Pinal R
Int J Pharm; 2010 Jun; 393(1-2):48-54. PubMed ID: 20363302
[TBL] [Abstract][Full Text] [Related]
3. Solubilization of poorly soluble compounds using 2-pyrrolidone.
Jain P; Yalkowsky SH
Int J Pharm; 2007 Sep; 342(1-2):1-5. PubMed ID: 17570624
[TBL] [Abstract][Full Text] [Related]
4. Cosolvency and deviations from log-linear solubilization.
Rubino JT; Yalkowsky SH
Pharm Res; 1987 Jun; 4(3):231-6. PubMed ID: 3509286
[TBL] [Abstract][Full Text] [Related]
5. Cosolvency and cosolvent polarity.
Rubino JT; Yalkowsky SH
Pharm Res; 1987 Jun; 4(3):220-30. PubMed ID: 3509285
[TBL] [Abstract][Full Text] [Related]
6. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
[TBL] [Abstract][Full Text] [Related]
7. Solubility of hydrophobic compounds in water-cosolvent mixtures: relation of solubility with water-cosolvent interactions.
Miyako Y; Zhao Y; Takeshima K; Kataoka T; Handa T; Pinal R
J Pharm Sci; 2010 Jan; 99(1):293-302. PubMed ID: 19548311
[TBL] [Abstract][Full Text] [Related]
8. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
9. A new definition of solubilization power of a cosolvent.
Jouyban A; Fakhree MA
Pharmazie; 2008 Apr; 63(4):317-9. PubMed ID: 18468394
[TBL] [Abstract][Full Text] [Related]
10. Solubility improvement of drugs using N-methyl pyrrolidone.
Sanghvi R; Narazaki R; Machatha SG; Yalkowsky SH
AAPS PharmSciTech; 2008; 9(2):366-76. PubMed ID: 18431671
[TBL] [Abstract][Full Text] [Related]
11. The use of N-methylpyrrolidone as a cosolvent and oxidant in pharmaceutical stress testing.
Reynolds DW; Galvani M; Hicks SR; Joshi BJ; Kennedy-Gabb SA; Kleinman MH; Parmar PZ
J Pharm Sci; 2012 Feb; 101(2):761-76. PubMed ID: 22083665
[TBL] [Abstract][Full Text] [Related]
12. Solubilization by cosolvents. Establishing useful constants for the log-linear model.
Millard J; Alvarez-Núñez F; Yalkowsky S
Int J Pharm; 2002 Oct; 245(1-2):153-66. PubMed ID: 12270252
[TBL] [Abstract][Full Text] [Related]
13. Estimation of drug precipitation upon dilution of pH-cosolvent solubilized formulations.
Narazaki R; Sanghvi R; Yalkowsky SH
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1203-6. PubMed ID: 17666845
[TBL] [Abstract][Full Text] [Related]
14. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
Thakur R; Gupta RB
Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
[TBL] [Abstract][Full Text] [Related]
15. Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures.
Yalkowsky SH; Rubino JT
J Pharm Sci; 1985 Apr; 74(4):416-21. PubMed ID: 3999002
[TBL] [Abstract][Full Text] [Related]
16. Toxicity Study of a Self-nanoemulsifying Drug Delivery System Containing N-methyl pyrrolidone.
Agrawal AG; Kumar A; Gide PS
Drug Res (Stuttg); 2015 Aug; 65(8):446-8. PubMed ID: 25823509
[TBL] [Abstract][Full Text] [Related]
17. Solubility screening on a series of structurally related compounds: cosolvent-induced changes on the activity coefficient of hydrophobic solutes.
Miyako Y; Tai H; Ikeda K; Kume R; Pinal R
Drug Dev Ind Pharm; 2008 May; 34(5):499-505. PubMed ID: 18473232
[TBL] [Abstract][Full Text] [Related]
18. Dependence of solute solubility parameters on solvent polarity.
Martin A; Wu PL; Liron Z; Cohen S
J Pharm Sci; 1985 Jun; 74(6):638-42. PubMed ID: 3839531
[TBL] [Abstract][Full Text] [Related]
19. The effects of pH and mixed solvent systems on the solubility of oxytetracycline.
Tongaree S; Flanagan DR; Poust RI
Pharm Dev Technol; 1999; 4(4):571-80. PubMed ID: 10578512
[TBL] [Abstract][Full Text] [Related]
20. Extended Hildebrand solubility approach and the log linear solubility equation.
Martin A; Wu PL; Adjei A; Lindstrom RE; Elworthy PH
J Pharm Sci; 1982 Aug; 71(8):849-56. PubMed ID: 7120084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
